Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology?

Reinhold Kreutza Charite – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of Clinical Pharmacology and Toxicology, Berlin, GermanyCorrespondence[email protected]
View further author information

Michel Azizib Universite Paris Cite, Paris, France; AP-HP Hopital Europeen Georges-Pompidou, Hypertension Department and DMU CARTEView further author information

Guido Grassic Clinica Medica, University Milano-Bicocca, Milan, ItalyView further author information

Andrzej Januszewiczd Department of Hypertension, National Institute of Cardiology, Warsaw, PolandView further author information

Thomas Kahane Karolinska Institutet, Departement of Clinical Sciences, Danderyd Hospital, Division of Cardiovascular Medicine, Stockholm, SwedenView further author information

Empar Lurbef Consorcio Hospital General Universitario de Valencia, Valencia, Biomedical Research Networking Center for Physiopathology of Obesity and Nutrition (CIBEROBN), Institute of Health Carlos III (ISCIII), Madrid, University of Valencia, Valencia, SpainView further author information

Jorge Poloniag CINTESIS; Faculty of Medicine of Porto, PortugalView further author information

Konstantinos Tsioufish First Department of Cardiology, Medical School, University of Athens, Hippokration Hospital, Athens, GreeceView further author information

Thomas Weberi Cardiology Department, Klinikum Wels-Grieskirchen, Wels, AustriaView further author information

Bryan Williamsj Institute of Cardiovascular Sciences, University College London (UCL), National Institute for Health Research UCL Hospitals Biomedical Research Centre, London, UKView further author information

Giuseppe Manciak University of Milano-Bicocca, Milan, ItalyCorrespondence[email protected]
View further author information

show all